Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoHealth, Inc. - Class A Common Stock (NQ:GOCO)

3.380 -0.020 (-0.59%)
Streaming Delayed Price Updated: 1:41 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,597
Open 3.400
Bid (Size) 3.320 (200)
Ask (Size) 3.400 (100)
Prev. Close 3.400
Today's Range 3.320 - 3.400
52wk Range 3.320 - 21.00
Shares Outstanding 1,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GoHealth to Announce Third Quarter 2025 Results on November 13, 2025
From GoHealth, Inc.
Via GlobeNewswire
GoHealth Helps Medicare Consumers Navigate Another Disruptive Annual Enrollment Period (AEP) With Personalized Guidance
As millions of Medicare beneficiaries face significant plan disruption for 2026, GoHealth aims to deliver peace of mind 
From GoHealth, Inc.
Via GlobeNewswire

Performance

YTD
-75.7%
-75.7%
1 Month
-23.2%
-23.2%
3 Month
-41.4%
-41.4%
6 Month
-58.4%
-58.4%
1 Year
-70.7%
-70.7%

More News

Read More
5 Financial Stocks Struggle With Expansion, Lagging Behind Sector Peers
Via Benzinga
Earnings Scheduled For August 7, 2025
Via Benzinga
Stonegate Capital Partners Updates Coverage On GoHealth Inc. (GOCO) 2025 Q2
Via Newsfile
GoHealth Inc. (NASDAQ:GOCO) Reports Q2 2025 Earnings Miss Amid Revenue Decline and Strategic Restructuring
Via Chartmill
Topics Earnings
GoHealth Announces Strategic Capital and Governance Actions to Support Long-Term Value Creation and Reports Second Quarter 2025 Results
From GoHealth, Inc.
Via GlobeNewswire
GoHealth to Announce Strategic Capital and Governance Actions to Support Long-Term Value Creation and Second Quarter 2025 Results
From GoHealth, Inc.
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, and Cleveland-Cliffs and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
GoHealth Secures Amended Credit Agreement Highlighting Broad Based Support from Stakeholders
From GoHealth, Inc.
Via GlobeNewswire
GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating GoHealth and Abacus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO
From Pomerantz LLP
Via GlobeNewswire
GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating TechTarget, SelectQuote, GoHealth, and Cleveland-Cliffs and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO
From Pomerantz LLP
Via GlobeNewswire
GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Organon, Landstar, Arvinas, and GoHealth and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is GoHealth, Inc. - Class A Common Stock publicly traded?
Yes, GoHealth, Inc. - Class A Common Stock is publicly traded.
What exchange does GoHealth, Inc. - Class A Common Stock trade on?
GoHealth, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GoHealth, Inc. - Class A Common Stock?
The ticker symbol for GoHealth, Inc. - Class A Common Stock is GOCO on the Nasdaq Stock Market
What is the current price of GoHealth, Inc. - Class A Common Stock?
The current price of GoHealth, Inc. - Class A Common Stock is 3.380
When was GoHealth, Inc. - Class A Common Stock last traded?
The last trade of GoHealth, Inc. - Class A Common Stock was at 11/11/25 01:41 PM ET
What is the market capitalization of GoHealth, Inc. - Class A Common Stock?
The market capitalization of GoHealth, Inc. - Class A Common Stock is 3.38K
How many shares of GoHealth, Inc. - Class A Common Stock are outstanding?
GoHealth, Inc. - Class A Common Stock has 3K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.